Information on the target
Synecco, headquartered in Galway, Ireland, is a prominent player in the medtech sector, specializing in the design, development, and contract manufacturing of advanced medical delivery systems. Established in 2004, the company has built a strong reputation for its expertise in structural heart technologies, neonatal feeding solutions, and injection molding. Synecco's commitment to engineering excellence and innovative manufacturing processes enables healthcare innovators to bring reliable, high-performance medical devices to market efficiently.
With operations in County Clare, Ireland, and a global presence in China, Synecco serves both the Irish market and mainland Europe. The company emphasizes a design-led approach, offering end-to-end product development that encompasses concept design, engineering, injection molding, assembly, and supply chain integration. Synecco's collaborative model fosters close partnerships with clients, ensuring the creation of user-centered devices that accelerate market launch.
Industry overview in the target’s specific country
The medtech industry in Ireland has experienced significant growth in recent years, positioning the country as a leading hub for medical device manufacturing in Europe. With a robust ecosystem that includes a skilled workforce, favorable regulatory environment, and strong government support, Ireland has attracted numerous global medtech companies. The country is home to over 300 medtech firms, contributing to a thriving sector that generates substantial revenue and employment opportunities.
In particular, Ireland's expertise in areas such as cardiovascular devices, orthopedics, and diagnostics has made it a focal point for innovation and development. The presence of major multinational corporations, alongside a vibrant network of small to medium-sized enterprises, fosters collaboration and knowledge sharing, driving advancements in medical technology. Furthermore, Ireland's strategic location provides easy access to European and global markets, enhancing its attractiveness as a manufacturing base.
As healthcare demands evolve, the medtech industry in Ireland is poised for continued growth, driven by advancements in technology and an increasing focus on patient-centered solutions. The integration of digital health technologies, such as telemedicine and remote monitoring, is expected to further transform the landscape, creating new opportunities for companies like Synecco to innovate and expand their offerings.
The rationale behind the deal The acquisition of Synecco by Arterex represents a strategic move to enhance Arterex's product offerings and expand its footprint in the European market. By integrating Synecco's advanced capabilities in design and development, particularly in structural heart technologies, Arterex …